Kevin O’Connor, Ph.D., a partner in the firm’s Intellectual Property practice group, was recently quoted in the Endpoints News article “Industry Groups Call to Block WTO IP Waiver Expansion to COVID-19 Therapeutics.” The article discusses differing perspectives on possible actions of the WTO regarding extending the vaccine waiver that is currently in place.

Click here to read the article.